Please login to the form below

Not currently logged in
Email:
Password:

Pharma trends

This page shows the latest Pharma trends news and features for those working in and with pharma, biotech and healthcare.

La La Land? The myth of multichannel excellence

La La Land? The myth of multichannel excellence

So. how are pharma companies faring? The simple answer is: many don’t know. ... It doesn’t. In fact, in an industry where investment in the field force bucks the trends of most other business sectors, pharma should do more to ensure that its MCM

Latest news

  • Top ten tech trends Top ten tech trends

    Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • 2017 pharma trends: Bon chance! 2017 pharma trends: Bon chance!

    A US take on the power shift in Washington and what it could mean for the industry

  • 2013: pharma's year of mobile? 2013: pharma's year of mobile?

    Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Assessing digital trends in pharma is fraught with a certain amount of difficulty.

  • Report to analyse patient-centricity in digital marketing Report to analyse patient-centricity in digital marketing

    The research programme will focus on drivers and trends, including pharma's growing awareness of the importance of customer engagement, the increasing use of social media in drug development, discovery and ... This will include analysis, data, trends,

  • Technology trends facing pharma in 2013 Technology trends facing pharma in 2013

    Context-based services and social media are among the major technology trends pharma will need to embrace in 2013. ... Internal use of social media in pharma also helps build confidence as companies can go beyond their organisation to engage with

More from news
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Tracking comms trends: beyond the event Tracking comms trends: beyond the event

    There’s no substitute for face-to-face meetings. But meetings require a significant investment, with often substantial venue and travel costs, as well as the opportunity costs  of the audience and organiser’s time. Therefore, it’s vital for

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    But some things stayed the same in 2016, including the therapeutic areas in which pharma was most interested. ... Digital health is expected to be a major investment area for a wider variety of pharma companies.

  • Transformational technology Transformational technology

    A wave of information. The meeting began by looking at the most important technology trends in pharma. ... In commercial pharma, adherence is a big challenge and opportunity” explained AstraZeneca's Matt Pammer.

  • Tracking comms trends: 2 + 2 = 7: bad maths, or good sense? Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

    The response from pharma though, has been encouraging. Economists, innovation hubs, a move to focus more on health outcomes than unit sales. ... For both of these trends we are seeing pharma look outside its own walls – fresh, unsullied thinking is

  • Tracking comms trends: Europe in the global vanguard on value Tracking comms trends: Europe in the global vanguard on value

    From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today. ... I n recent years European healthcare payers have harassed and challenged the pharma

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics